Date: March 1-4, 2020 Location: Moscone South Convention Center, San Francisco, CA  Attend our presentation or schedule a meeting with us here. Presentation: Blood and Urine-based Liquid Biopsy Solutions for TMB and MRD in Clinical Trials In this talk, we’ll present the development and clinical applications of blood and urine-based liquid biopsy solutions using cfDNA...

Date: February 13 – 15, 2020 Location: Moscone West Building, San Francisco, CA  In collaboration with Mayo Clinic, Lee Moffitt Cancer Center, Monash University, and Kintor Pharmaceuticals, we are proud to announce our 3 abstracts in prostate cancer at the American Society of Clinical Oncology – Genitourinary Cancers Symposium.  Stop by our poster presentations or...

Date: January 13 – 16, 2020 Location: Hilton Miami Downtown, Miami, FL In collaboration with Merck KGaA, we are proud to present “Simultaneous multi-parametric profiling of cell-free RNA (cfRNA) and cell-free tumor DNA (ctDNA) in advanced-stage colorectal cancer” at the AACR Special Conference on Advances in Liquid Biopsies, on Tuesday, January 14th at 4:00pm, poster...

Predicine and Merck KGaA, Darmstadt, Germany collaboratively highlight the importance of multi-parametric profiling of ctDNA and cfRNA for holistic molecular insight for detecting driver mutation, monitoring disease burden and drug resistance in advanced stage colorectal cancer. Predicine, a molecular insights company headquartered in Hayward, California, with global footprints in China, today announced results from a...

Predicine is committed to supporting next-generation scientists in biomedical sciences. Through Predicine Translational Research Award at Harvard Medical School’s New England Science Symposium 2020 (NESS), we encourage students and fellows to innovate and explore careers in STEM. Every year students and fellows from around the U.S. and the world converge at the NESS to share their research...